Explore a research direction

Biomedical engineering
research labs.

Explore labs that list biomedical engineering among their research interests, including work on devices, materials and tools for diagnosing and treating disease. Each profile links to its official sources so you can check what a group actually studies before you decide whom to contact.

What to compare

When comparing groups in biomedical engineering, look at the stage of development from concept to preclinical testing, and any regulatory or clinical collaborations. Ask how a new researcher would be involved and what preparation is expected.

Profiles appear here because their listed research keywords match this topic. Inclusion does not establish an open position. Check the official sources and any published application instructions before reaching out.

Prepare a research introduction ↗

60 research-led lab profiles

Browse labs by their listed college affiliation
SNIndependently curated · Unclaimed
Health Sciences and Technology; Electrical Engineering and Computer Science↗

Laboratory for Multiscale Regenerative Technologies (LMRT)

Massachusetts Institute of Technology

Sangeeta N. Bhatia · John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science

What if a tiny engineered tissue could reveal how a drug behaves in a human liver? Sangeeta Bhatia’s LMRT brings microfabrication, tissue engineering, and nanotechnology to that question. The group builds human liver models for studying drug responses and infections, and develops nanoscale tools for detecting and treating disease. Selected work includes a 3D model of the junction between liver tissue and bile ducts, and electrical stimulation to guide blood-vessel formation in engineered tissues. It is a place where device design meets cell biology, with experiments spanning molecules, cells, and tissue-scale systems.

Tissue engineeringNanotechnologyBiomedical engineering
SMIndependently curated · Unclaimed
↗

Lunte Research Group

University of Kansas

Susan M. Lunte · Ralph N. Adams Distinguished Professor of Chemistry and Pharmaceutical Chemistry

Measuring a biological signal is often the first obstacle to understanding it. Susan Lunte develops small-scale analytical methods for studying peptide transport and metabolism across the blood-brain barrier. Her group also builds separation-based sensors that combine microdialysis with microchip electrophoresis, cell-based assays on chips, and diagnostics for cardiovascular and metabolic disease. These projects connect analytical chemistry with neurochemistry and drug development. The research is a concrete match for interests in biosensing, microfluidic analysis, and monitoring molecules at biologically relevant concentrations.

Bioanalytical chemistryMicrochip electrophoresisBlood-brain barrier
MGIndependently curated · Unclaimed
Biomedical Engineering↗

Mark Grinstaff Research Group

Boston University

Mark Grinstaff · William Fairfield Warren Distinguished Professor

How can biological and macromolecular chemistry guide the design of new biomaterials? The Grinstaff Group pursues highly interdisciplinary research in the areas of biological and macromolecular chemistry. The group designs, synthesizes, and characterizes novel dendrimers for tissue engineering and biotechnological applications. These biomaterials are being evaluated for the repair of corneal lacerations, the delivery of anti-cancer drugs, the delivery of DNA, and as temporary biodegradable scaffolds for cartilage repair. The group also creates polymeric coatings that control biology on plastic, metal, and ceramic surfaces.

biomaterialsmacromolecular chemistrydendrimers
MPIndependently curated · Unclaimed
↗

Mark Prausnitz Research Group

Georgia Institute of Technology

Mark Prausnitz · Regents' Professor

How can physical forces move drugs, proteins, genes, and vaccines into and within the body in a minimally invasive way? The research uses microneedles, ultrasound, lasers, electric fields, heat, and convective forces to control how therapeutic molecules cross tissue barriers. A major focus is microneedle patches that apply vaccines to the skin painlessly, including a self-administered influenza vaccine under development. Hollow microneedles developed by the group inject into the skin, where research focuses on insulin administration to diabetic patients, and into the eye, to treat macular degeneration and other retinal diseases. Further studies examine how cavitation bubbles from ultrasound or laser-excited carbon nanoparticles break open a small section of the cell membrane, enabling entry of molecules for gene-based therapies.

microneedle patchesdrug deliveryvaccine delivery
MWIndependently curated · Unclaimed
↗

Matthew Webber Research Group

University of Notre Dame

Matthew Webber · Keating-Crawford Collegiate Professor of Engineering

How can non-covalent molecular recognition motifs be used to engineer dynamic biomaterials? Supramolecular biomaterials use non-covalent molecular recognition motifs to engineer highly tunable, dynamic, modular, and bioactive materials for biomedical and biological applications. Another area is smart drug delivery and diagnostics, with strategies to deliver drugs, therapeutic proteins, or diagnostic agents. Bio-inspired materials are engineered using nature as inspiration or using natural frameworks. Supramolecular chemistry work develops new supramolecular motifs that afford enhanced affinity, improved biocompatibility, and/or more precise biomimicry.

supramolecular biomaterialsdrug deliverybio-inspired materials
MAIndependently curated · Unclaimed
Electrical and Computer Engineering↗

Muhammad Ashraful Alam Research Group

Purdue University West Lafayette

Muhammad Ashraful Alam · Gupta Distinguished Professor of Electrical and Computer Engineering

What governs the physics of electronic, optoelectronic and bioelectronic devices? Muhammad Ashraful Alam's listed research covers the physics of these devices, transport in inhomogeneous systems, reliability limits of CMOS devices and computational modeling. His engineering profile describes performance and reliability physics of transistors, biosensors and solar cells. This work is described as addressing fundamental challenges in computing, communication, renewable energy and healthcare. His listed area of interest is microelectronics and nanotechnology, and he is the Jai N. Gupta Distinguished Professor of Electrical and Computer Engineering.

device physicsreliabilitybiosensors
VNIndependently curated · Unclaimed
↗

Nanda Lab

Rutgers University–New Brunswick

Vikas Nanda · Professor

Can proteins be designed to perform functions that natural evolution has not supplied? The Nanda Lab develops computational tools for protein design, structure prediction, and molecular docking. Its projects include designing collagen based extracellular matrices, studying how nonnatural amino acids affect peptide stability, and investigating the relationship between protein digestion and food allergy. Designed matrices are characterized experimentally to examine how their chemical and spatial organization influences cells. The work links structural biology and molecular evolution to biomaterials and possible biomedical applications.

Computational protein designCollagenBiomaterials
LHIndependently curated · Unclaimed
↗

Nanobiomechanics Laboratory

Drexel University

Lin Han · Professor of Biomedical Engineering

Why does a tiny change in tissue structure alter the way a joint works? Lin Han investigates the nanoscale relationships between the structure and properties of biological materials. His research examines genetic and molecular origins of soft joint tissue diseases, biomaterials under extreme conditions, and the connections between geometry and stimulus response. The work aims to inform disease diagnostics, tissue regeneration, and bio-inspired material design. It connects biomechanics with materials science for researchers interested in understanding tissue function from its smallest structural features.

NanobiomechanicsJoint tissueBiomaterials
RIIndependently curated · Unclaimed
↗

Nanomedicines and Translational Research Laboratory

University of Nebraska Medical Center

Ram I. Mahato · Professor

Mahato investigates how a therapy reaches the tissue where it is needed. His Nanomedicines and Translational Research Laboratory develops micelles, nanoparticles, polymers, and lipid-based systems for delivering drugs and nucleic acids, including siRNA and miRNA. Projects examine cancer, liver disease, and type 1 diabetes, alongside approaches to drug resistance and disease-related signaling. The group studies how delivery-system components affect drug deposition, tumor vessels, and surrounding tissue. This connects chemistry and formulation design with biological evaluation, aiming to improve targeted delivery and reduce unwanted effects on healthy tissue.

NanomedicineDrug deliveryNucleic-acid delivery
NSIndependently curated · Unclaimed
↗

Nathan Swami Research Group

University of Virginia (Main campus)

Nathan Swami · Professor of Electrical & Computer Engineering and Chemistry

Can small electrical and microfluidic devices reveal differences between cells that conventional measurements miss? The group develops microsystems for separating biological samples and detecting their characteristics. Research includes electrochemical measurements in droplets and microfluidic channels, soft-material platforms, and label-free methods that measure single-cell electrical impedance and deformability. These approaches investigate heterogeneity in stem cells, tumor cells, microbes and extracellular vesicles. The work connects biological samples with devices, circuits and signal analysis, with applications in regenerative biomanufacturing and diagnostics in settings with limited resources.

MicrofluidicsSingle-cell analysisBiosensors
OVIndependently curated · Unclaimed
Departments of Bioengineering and Chemical and Biomolecular Engineering↗

Omid Veiseh Research Group

Rice University

Omid Veiseh · Professor of Bioengineering

How can engineered biomaterials control host immune responses to enable long-term function of implanted therapeutic devices? The group develops implantable multi-scale devices and biomaterials for cell transplantation, localized controlled drug release, continuous sensing, and tissue regeneration. They combine nano-, micro-, and macro-scale fabrication with molecular engineering and cellular and molecular biology methods to tune geometry, porosity, mechanical stiffness, and surface chemistry of materials. Researchers apply synthetic biology and immunoengineering to build cell-based platforms for real-time and feedback-regulated production of biologics. The team develops tools to non-invasively track cellular and biomolecular activity in vivo to assess host responses and device performance.

BiomaterialsBiofabricationImmunoengineering
QWIndependently curated · Unclaimed
↗

Qian Wang Research Group

University of South Carolina-Columbia

Qian Wang · Carolina Distinguished Professor

Qian Wang’s research connects bioconjugation chemistry with biomedical materials and nanoscale biological structures. One direction modifies and uses virus nanoparticles, treating their organized scaffolds as platforms that can be chemically engineered for new functions. Work also investigates virus-based scaffolds for immunotherapy. These projects bring organic chemistry, biology, and material design together around the task of attaching useful molecular features to structured biological objects. The program offers a connection between molecular modification and biomedical applications, exploring how naturally organized nanoscale systems can be repurposed through chemical design.

BioconjugationVirus nanoparticlesBiomaterials
RBIndependently curated · Unclaimed
Bioengineering↗

Rashid Bashir Research Group

University of Illinois at Urbana-Champaign

Rashid Bashir · Professor of Bioengineering

How can micro- and nanotechnology be applied to medical and biological problems? Rashid Bashir is Professor of Bioengineering, the Grainger Distinguished Chair in Engineering, and Dean of the Grainger College of Engineering. His research areas include biomechanics, BioMEMS, bionanotechnology, biosensors, multi-scale tissue engineering, and nanomedicine. He is described as a scholar in micro-fluidics and nanotechnology based diagnostic technologies for precision and personalized medicine. His scholarship also covers 3D bio-fabrication of multi-cellular engineered living systems for biological soft robotics.

BioMEMSbionanotechnologybiosensors
RBIndependently curated · Unclaimed
↗

Rena Bizios Research Group

The University of Texas at San Antonio

Rena Bizios · Lutcher Brown Endowed Distinguished University Chair Professor

Rena Bizios investigates the interface where living cells meet engineered materials. Her research examines cell–material and protein–material interactions, including responses to nanostructured biomaterials, with applications in implants, tissue engineering, and regeneration. Work also explores how physical stimuli such as pressure and electrical current influence cell functions relevant to new tissue formation. The program connects biomaterial design with cellular behavior, asking which features make a material compatible with biological systems and how engineered environments might support the repair or formation of functional tissue.

BiomaterialsCell-material interactionsTissue engineering
R“Independently curated · Unclaimed
Materials Science and Engineering↗

Renato “Sam” Navarro Research Group

University of Florida

Renato “Sam” Navarro · Assistant Professor

How can polymer networks be designed to tune hydrogel mechanics and control therapeutic release for tissue repair? Navarro's group synthesizes tailored polymers using controlled polymer synthesis and crosslinking chemistries to create hydrogels with programmable degradation and stiffness. They evaluate drug delivery by loading therapeutics into hydrogel matrices and measuring release kinetics under physiological conditions. The research develops bioprinting processes that deposit cell-laden or acellular bioinks to fabricate tissue-like constructs for regenerative testing. Materials characterization and in vitro assays probe cell–material interactions and mechanical properties to guide scaffold design for engineering applications.

biomaterialshydrogelspolymer synthesis
RLIndependently curated · Unclaimed
↗

Robert Langer Research Group

Massachusetts Institute of Technology

Robert Langer · David H. Koch (1962) Institute Professor

How can engineered polymers carry drugs, proteins, and genetic material into the body and release them steadily over long periods? The lab develops polymers that provide continuous controlled-rate delivery of genetically engineered proteins and DNA for prolonged periods of time. Related work builds selective drug or substance removal systems that may circumvent toxicity from drugs or other substances. Another effort develops drugs that specifically inhibit neovascularization, a process that is critical to several disease processes, without disturbing existing blood vessels. Tissue engineering efforts synthesize biodegradable polymer systems for mammalian cell transplants to create liver, cartilage, and nerves, and develop bioreactors for these purposes.

drug deliverypolymersbiomaterials
RSIndependently curated · Unclaimed
↗

Rohan Shirwaiker Research Group

North Carolina State University

Rohan Shirwaiker · James T. Ryan Distinguished Professor

How can manufacturing methods produce biological materials with the structure and functional properties needed for medicine and sustainable food? The group combines computational modeling, experiments and data analysis to design processes for making products with biomimetic attributes. Its tissue-manufacturing research develops ultrasound-assisted bioprinting and three-dimensional melt and solution blowing for engineered medical products. Researchers also investigate non-destructive quality measurements using dielectric and ultrasound spectroscopy to assess these biological products. The work connects manufacturing settings, biomaterials and functional quality, while the broader research program includes sustainable protein applications.

BiomanufacturingTissue engineeringBioprinting
SMIndependently curated · Unclaimed
Bioengineering↗

Samir Mitragotri Research Group

Harvard University

Samir Mitragotri · Hiller Professor of Bioengineering

How can drug delivery technologies convert potent drugs into beneficial therapies? Drug delivery is the science and engineering of converting potent drugs into beneficial therapies. The Mitragotri Laboratory for Drug Delivery is developing innovative technologies to tackle some of the major problems in human health. The lab has made contributions to the fields of drug delivery and biomaterials. The SEAS directory entry for Samir Mitragotri lists research areas that include Cell and Tissue Engineering, Biomaterials, and Therapeutics.

drug deliverybiomaterialsbioengineering
SKIndependently curated · Unclaimed
Bioengineering↗

Sanjay Kumar Research Group

University of California, Berkeley

Sanjay Kumar · Professor of Chemical and Biomolecular Engineering

How do mechanical and biophysical signals from the extracellular matrix regulate tumor invasion and neural stem cell fate? The lab engineers tissue‑mimetic culture platforms and biomaterials that control stiffness, ligand presentation, and topography to probe mechanotransduction. Researchers combine micro/nanofabricated platforms, traction and force measurements, and high‑resolution imaging to identify signaling pathways driving glioblastoma invasion and stem cell neurogenesis. Projects include engineered hyaluronic acid hydrogels and stress‑relaxation matrices to dissect TGF‑β and spectrin‑mediated mechanosensitive responses. Studies use molecular perturbations and multiomic screening to link matrix mechanics to invasion‑relevant biochemical pathways.

mechanobiologybiomaterialsglioblastoma
SHIndependently curated · Unclaimed
Coulter Department of Biomedical Engineering↗

Scott Hollister Research Group

Georgia Institute of Technology

Scott Hollister · Professor

How can image-based computational design and 3D biomaterial printing produce patient specific devices? Scott Hollister is a Professor of Biomedical Engineering at the Georgia Institute of Technology. He directs the Center for 3D Medical Fabrication. He also directs the Tissue Engineering and Mechanics Laboratory. Clinical application interests include airway reconstruction and tissue engineering, structural heart defects, and craniofacial and facial plastics. The page describes multiscale computational simulation of how devices and implants mechanically interact with patient designs.

3D printed medical devicespatient specific devicesregenerative medicine
SOIndependently curated · Unclaimed
↗

Shana O. Kelley Research Group

Northwestern University

Shana O. Kelley · Professor

Can continuous, reagentless sensors enable real-time molecular monitoring in living systems with high specificity? The Kelley Group develops biomolecular sensors and active-reset protein sensors for continuous in vivo monitoring of inflammation and other protein biomarkers. The group builds high-throughput microfluidic and immunomagnetic platforms for rare and single-cell analysis to enable cell therapy development and liquid biopsy assays. Researchers design peptide- and nanoparticle-based intracellular delivery vectors to control intracellular localization and enhance mitochondrial targeting of synthetic molecules. The team combines CRISPR screening, cellular engineering, and nanoscale electrochemical methods to build diagnostic and phenotypic screening tools.

biomedical engineeringbiomolecular sensorsnanotechnology
SJIndependently curated · Unclaimed
Meinig School of Biomedical Engineering↗

Shaoyi Jiang Research Group

Cornell University

Shaoyi Jiang · Robert Langer ’70 Family and Friends Professor

How can unwanted nonspecific biomolecular and microorganism attachment on surfaces be prevented? The group developed several new classes of zwitterionic materials, including poly(carboxybetaine), poly(sulfobetaine), and poly(trimethylamine N-oxide). At Cornell, the group aims to integrate immunology into its biomaterial and drug delivery research programs. One area is developing highly biocompatible materials, which are either biologically inert or immunomodulatory, using both rational design and combinatorial screening. A second area is low-immunogenic and targeted drug delivery, one of the two areas the group focuses on.

zwitterionic materialsbiomaterialsdrug delivery
SSIndependently curated · Unclaimed
↗

Shay Soker Research Group

Wake Forest University

Shay Soker · Professor

Soker builds small tissue models to investigate how organs develop and how disease changes them. His laboratory combines cell sources, extracellular-matrix scaffolds, tissue vascularization, and imaging to construct bioengineered tissues. Work described by Wake Forest includes miniature human liver constructs and organoids for studying fibrosis, cancer, and drug responses. He also leads the scientific program of the Wake Forest Organoid Research Center. For prospective researchers, this offers a connection between regenerative engineering and disease modeling, with patient-derived cells and three-dimensional tissue environments helping frame more realistic experimental questions.

OrganoidsExtracellular matrixTissue engineering
SNIndependently curated · Unclaimed
↗

Shikha Nangia Research Group

Syracuse University

Shikha Nangia · Professor

Shikha Nangia’s group models biological barriers at molecular scales to understand why some drugs cannot reach their targets. A central project examines the architecture of the blood-brain barrier and possible pathways for transporting therapeutic molecules into the brain. Multiscale computational work also covers membrane proteins, lipid and bacterial membranes, disordered proteins, drug delivery, and responsive polymers. The program connects engineering, chemistry, biophysics, and computation with experimental collaborations. Its simulations explore mechanisms and design possibilities relevant to disease research without treating modeled delivery strategies as established therapies.

Blood-brain barrierMolecular simulationDrug delivery

Showing 25–48 of 60 labs

Explore the listed universities